Table II.
Prevalence of Cardiometabolic Risk Factors byWCand BMI Levels
| BP ≥140/90 |
HDL-C <40 (women/50 (men) mg/dL |
TG ≥150 mg/dL |
Glucose ≥100 mg/dL |
hs-CRPa ≥3.0 mg/L |
LpPLA2 ≥217 mg/L |
Global Riskb ≥10% |
|
|---|---|---|---|---|---|---|---|
| WC, >35 (women)/>40 (men) in | 30% | 33% | 31% | 49% | 39% | 27% | 11% |
| BMI, ≥25 kg/m2 | 28% | 29% | 28% | 45% | 30% | 27% | 11% |
| BMI, ≥30 kg/m2 | 30% | 35% | 35% | 46% | 41% | 28% | 12% |
| Central adiposityc | 28% | 28% | 28% | 45% | 29% | 28% | 11% |
Abbreviations: BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LpPLA2, lipoprotein-associated phospholipase A2; TG, triglycerides; WC, waist circumference.
a
Excluding hs-CRP ≥10.
b
Calculated using the Framingham function.
c
Defined as BMI ≥25 kg/m2 andWC>35 in (women) or 40 in (men) vs BMI <25 kg/m2 andWC≤35 in (women) or 40 in (men).